唐氏综合征中的内体失调:阿尔茨海默病病理的潜在贡献者
本文综述内体系统在维持神经元功能中的作用,指出唐氏综合征患者常出现阿尔茨海默病(AD)样病理及内体形态、数量、溶酶体酸化和外泌体分泌异常。文章重点讨论逆转体(retromer)和逆转器(retriever)两条内体途径,探讨其作为唐氏综合征中AD样病理新治疗靶点的潜力。
要点
- 唐氏综合征患者多数会发展出AD病理,并伴有内体系统异常。
- 逆转体复合体介导的内体运输途径可能与唐氏综合征的AD样表型相关。
- 逆转器是与逆转体结构相关的新内体系统,其致病作用尚不明确。
核心结论
- 内体系统功能紊乱,尤其是逆转体和逆转器途径的异常,可能是唐氏综合征中AD样病理的重要贡献因素,并具有治疗靶点潜力。
研究设计与样本
- 本文为综述,回顾内体系统神经生物学及其在唐氏综合征AD样病理中的作用,并讨论逆转体和逆转器系统作为治疗靶点的现有知识。
主要发现
- 唐氏综合征患者多数发展出AD病理,并表现出内体形态和数量改变、溶酶体酸化异常及外泌体分泌异常。
- 逆转体复合体负责将货物从内体运输至反式高尔基网络或细胞膜,其神经病理生理学已有较多认识。
- 逆转器是结构与逆转体相关的新内体系统,目前尚未明确其精确的致病作用。
局限性
- 逆转器在唐氏综合征AD样病理中的精确致病作用尚未明确。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Intracellular protein trafficking via the endosomes plays a key role in the maintenance of normal neuronal function. Although many diseases of the central nervous system exhibit specific pathological hallmarks, abnormalities of the endosome system are common traits for several of them, including Alzheimer disease (AD). Three main routes originate from the endosomes: the recycling, degradation, and retrograde pathways. Studies have shown that the majority of Down syndrome subjects develop AD pathology and manifest altered morphology and number of endosomes, and abnormalities in lysosome acidification and exosome secretion, suggesting that dysfunction of one of these pathways could play a functional role in the AD-like phenotype of the syndrome. Two of the major endosomal routes are mediated by the retromer complex, a multimeric system responsible for transport of cargo from the endosome to the trans-Golgi network or to the cell membrane. Recently, a new endosome system structurally related to the retromer, called "retriever," has been reported. Whereas we know a great deal about the neuropathophysiology of the retromer complex, no precise pathogenic role for the retriever has yet been identified. Here, we will review the neurobiology of the endosome system and its role as key player in the development of AD-like pathology in Down syndrome. Additionally, we will discuss current knowledge on these two main endosome systems, retromer and retriever, and their potential as novel therapeutic targets. ANN NEUROL 2021;90:4-14.
引用
- Filippone A, Praticò D. Endosome Dysregulation in Down Syndrome: A Potential Contributor to Alzheimer Disease Pathology. Ann Neurol. 2021. PMID: 33547827. doi:10.1002/ana.26042
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。